Alijanzadeh Dorsa, Karimi Hanie, Masoumi Niloofar, Kazemzadeh Kimia, Samieefar Noosha, Mesdaghi Mehrnaz
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Network of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Pathog Glob Health. 2025 Feb-Mar;119(1-2):60-72. doi: 10.1080/20477724.2024.2439740. Epub 2024 Dec 17.
The coronavirus disease 2019 (COVID-19) pandemic has disrupted polio immunization programs worldwide. The consequences of these programs' suspension were not fully presented during the COVID-19 pandemic, as some take time to present in a population. We conducted a narrative review to provide a perspective of current literature on the effect of the COVID-19 pandemic on efforts made for poliomyelitis eradication. An overview of potential risks of polio outbreaks and areas where wild and vaccine-derived polioviruses have been reported will be presented in this review. Decreased vaccination rate, human and financial resources diversion to tackle COVID-19, and polio surveillance suspension during the COVID-19 pandemic contributed to creating an immunity gap and increasing the risk of polio outbreaks in at-risk areas. Approaches for integrating immunization efforts with educating the general population, engaging religious leaders, and solving gender disparities to fill the gap that have been made during the pandemic. The path to control polio should engage different levels of policy-making, and governments of affected countries play crucial roles. Strong interdisciplinary collaboration and dedicated efforts are needed to inform policymakers and encourage the public to follow vaccination programs.
2019年冠状病毒病(COVID-19)大流行扰乱了全球脊髓灰质炎免疫规划。这些规划暂停的后果在COVID-19大流行期间并未完全显现,因为其中一些后果需要时间才能在人群中显现出来。我们进行了一项叙述性综述,以提供关于COVID-19大流行对根除脊髓灰质炎努力影响的当前文献观点。本综述将概述脊髓灰质炎暴发的潜在风险以及报告野生和疫苗衍生脊髓灰质炎病毒的地区。COVID-19大流行期间疫苗接种率下降、人力和财力资源转向应对COVID-19以及脊髓灰质炎监测暂停,导致出现免疫差距,并增加了高危地区脊髓灰质炎暴发的风险。在大流行期间,将免疫工作与教育普通民众、争取宗教领袖参与以及解决性别差异相结合以填补差距的方法。控制脊髓灰质炎的道路应涉及不同层面的决策,受影响国家的政府发挥关键作用。需要强有力的跨学科合作和专门努力,为政策制定者提供信息,并鼓励公众遵循疫苗接种规划。